Dissecting the origin of breast cancer subtype stem cell and the potential mechanism of malignant transformation

PLoS ONE

Volumn 11, Issue 10, 2016, Pages

  Liu, Xinyi ^a   Feng, Dongfei ^a,b   Liu, Dianming ^a   Wang, Shuyuan ^a   Yu, Xuexin ^a   Dai, Enyu ^a   Wang, Jing ^a   Wang, Lihong ^a   Jiang, Wei ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Harbin Children's Hospital 150020   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX10;

ARTICLE; BINDING SITE; BIPOTENT ENRICHED PROGENITOR CELL; BREAST CANCER; BREAST CANCER SUBTYPE STEM CELL; BREAST CARCINOGENESIS; BREAST CELL; CANCER STEM CELL; COMPARATIVE STUDY; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INTERACTION; GENE SIGNATURE; GENETIC HETEROGENEITY; GENETIC PARAMETERS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LUMINAL A BREAST CANCER; LUMINAL B BREAST CANCER; MALIGNANT TRANSFORMATION; MITOCHONDRIAL RESPIRATORY CHAIN; ONCOGENE NEU; PROGENITOR CELL LINE; PROTEIN INTERACTION; RESPIRATORY CHAIN; TRANSCRIPTION REGULATION; BREAST TUMOR; CELL TRANSFORMATION; FEMALE; GENE EXPRESSION PROFILING; GENETICS; PATHOLOGY;

BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION PROFILING; HUMANS; NEOPLASTIC STEM CELLS; TRANSCRIPTION, GENETIC;

EID: 84992337611     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0165001     Document Type: Article

References (53)

1. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, et al. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer research. 2006; 66(19):9339-44. doi: 10.1158/0008-5472.CAN-06-3126 PMID: 16990346
2. Grillet F, Bayet E, Villeronce O, Zappia L, Lagerqvist EL, Lunke S, et al. Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture. Gut. 2016.
3. Yang Z, Li C, Liu H, Zhang X, Cai Z, Xu L, et al. Single-cell sequencing reveals variants in ARID1A, GPRC5A and MLL2 driving self-renewal of human bladder cancer stem cells. European urology. 2016.
4. Creighton CJ, Li X, Landis M, Dixon JM, Neumeister VM, Sjolund A, et al. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proceedings of the National Academy of Sciences of the United States of America. 2009; 106(33):13820-5. doi: 10.1073/pnas.0905718106 PMID: 19666588
5. Dick JE. Stem cell concepts renew cancer research. Blood. 2008; 112(13):4793-807. doi: 10.1182/blood-2008-08-077941 PMID: 19064739
6. Zhou BB, Zhang H, Damelin M, Geles KG, Grindley JC, Dirks PB. Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nature reviews Drug discovery. 2009; 8(10):806-23. doi: 10.1038/nrd2137 PMID: 19794444
7. Nguyen LV, Vanner R, Dirks P, Eaves CJ. Cancer stem cells: an evolving concept. Nature reviews Cancer. 2012; 12(2):133-43. doi: 10.1038/nrc3184 PMID: 22237392
8. Bjerkvig R, Tysnes BB, Aboody KS, Najbauer J, Terzis AJ. Opinion: the origin of the cancer stem cell: current controversies and new insights. Nature reviews Cancer. 2005; 5(11):899-904. doi: 10.1038/nrc1740 PMID: 16327766
9. Wijaya L, Agustina D, Lizandi AO, Kartawinata MM, Sandra F. Reversing breast cancer stem cell into breast somatic stem cell. Current pharmaceutical biotechnology. 2011; 12(2):189-95. PMID: 21044008
10. Molyneux G, Geyer FC, Magnay FA, McCarthy A, Kendrick H, Natrajan R, et al. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell stem cell. 2010; 7(3):403-17. doi: 10.1016/j.stem.2010.07.010 PMID: 20804975
11. Bachoo RM, Maher EA, Ligon KL, Sharpless NE, Chan SS, You MJ, et al. Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer cell. 2002; 1(3):269-77. PMID: 12086863
12. Lottaz C, Beier D, Meyer K, Kumar P, Hermann A, Schwarz J, et al. Transcriptional profiles of CD133+ and CD133-glioblastoma-derived cancer stem cell lines suggest different cells of origin. Cancer research. 2010; 70(5):2030-40. doi: 10.1158/0008-5472.CAN-09-1707 PMID: 20145155
13. Boyle P. Triple-negative breast cancer: epidemiological considerations and recommendations. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO. 2012; 23 Suppl 6: vi7-12.
14. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000; 406(6797):747-52. doi: 10.1038/35021093 PMID: 10963602
15. Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ. Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO. 2011; 22(8):1736-47.
16. Seshie B, Adu-Aryee NA, Dedey F, Calys-Tagoe B, Clegg-Lamptey JN. A retrospective analysis of breast cancer subtype based on ER/PR and HER2 status in Ghanaian patients at the Korle Bu Teaching Hospital, Ghana. BMC clinical pathology. 2015; 15:14. doi: 10.1186/s12907-015-0014-4 PMID: 26161039
17. Raouf A, Zhao Y, To K, Stingl J, Delaney A, Barbara M, et al. Transcriptome analysis of the normal human mammary cell commitment and differentiation process. Cell stem cell. 2008; 3(1):109-18. doi: 10.1016/j.stem.2008.05.018 PMID: 18593563
18. Simon R, Lam A, Li MC, Ngan M, Menenzes S, Zhao Y. Analysis of gene expression data using BRBArrayTools. Cancer informatics. 2007; 3:11-7. PMID: 19455231
19. Yu G, Li F, Qin Y, Bo X, Wu Y, Wang S. GOSemSim: an R package for measuring semantic similarity among GO terms and gene products. Bioinformatics. 2010; 26(7):976-8. doi: 10.1093/bioinformatics/btq064 PMID: 20179076
20. Aerts S, Lambrechts D, Maity S, Van Loo P, Coessens B, De Smet F, et al. Gene prioritization through genomic data fusion. Nature biotechnology. 2006; 24(5):537-44. doi: 10.1038/nbt1203 PMID: 16680138
21. Stuart JM, Segal E, Koller D, Kim SK. A gene-coexpression network for global discovery of conserved genetic modules. Science. 2003; 302(5643):249-55. doi: 10.1126/science.1087447 PMID: 12934013
22. Wu G, Stein L. A network module-based method for identifying cancer prognostic signatures. Genome biology. 2012; 13(12):R112. doi: 10.1186/gb-2012-13-12-r112 PMID: 23228031
23. Kel AE, Gossling E, Reuter I, Cheremushkin E, Kel-Margoulis OV, Wingender E. MATCH: A tool for searching transcription factor binding sites in DNA sequences. Nucleic acids research. 2003; 31 (13):3576-9. PMID: 12824369
24. Mazandu GK, Mulder NJ. Information content-based gene ontology semantic similarity approaches: toward a unified framework theory. BioMed research international. 2013; 2013:292063. doi: 10.1155/2013/292063 PMID: 24078912
25. Zhang J, Jiang M, Yuan F, Feng KY, Cai YD, Xu X, et al. Identification of age-related macular degeneration related genes by applying shortest path algorithm in protein-protein interaction network. BioMed research international. 2013; 2013:523415. doi: 10.1155/2013/523415 PMID: 24455700
26. Li BQ, You J, Chen L, Zhang J, Zhang N, Li HP, et al. Identification of lung-cancer-related genes with the shortest path approach in a protein-protein interaction network. BioMed research international. 2013; 2013:267375. doi: 10.1155/2013/267375 PMID: 23762832
27. Strogatz SH. Exploring complex networks. Nature. 2001; 410(6825):268-76. doi: 10.1038/35065725 PMID: 11258382
28. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proceedings of the National Academy of Sciences of the United States of America. 2001; 98(19):10869-74. doi: 10.1073/pnas. 191367098 PMID: 11553815
29. Dontu G, El-Ashry D, Wicha MS. Breast cancer, stem/progenitor cells and the estrogen receptor. Trends in endocrinology and metabolism: TEM. 2004; 15(5):193-7. doi: 10.1016/j.tem.2004.05.011 PMID: 15223047
30. Melchor L, Benitez J. An integrative hypothesis about the origin and development of sporadic and familial breast cancer subtypes. Carcinogenesis. 2008; 29(8):1475-82. doi: 10.1093/carcin/bgn157 PMID: 18596026
31. Ringner M, Staaf J, Jonsson G. Nonfamilial breast cancer subtypes. Methods Mol Biol. 2013; 973:279-95. doi: 10.1007/978-1-62703-281-0-18 PMID: 23412797
32. Witkiewicz AK, Knudsen ES. Retinoblastoma tumor suppressor pathway in breast cancer: prognosis, precision medicine, and therapeutic interventions. Breast cancer research: BCR. 2014; 16(3):207. doi: 10.1186/bcr3652 PMID: 25223380
33. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nature genetics. 2000; 25(1):25-9. doi: 10.1038/75556 PMID: 10802651
34. Wang J, Zhou X, Zhu J, Gu Y, Zhao W, Zou J, et al. GO-function: deriving biologically relevant functions from statistically significant functions. Briefings in bioinformatics. 2012; 13(2):216-27. doi: 10.1093/bib/bbr041 PMID: 21705405
35. Ma J, Zhang Q, Chen S, Fang B, Yang Q, Chen C, et al. Mitochondrial dysfunction promotes breast cancer cell migration and invasion through HIF1alpha accumulation via increased production of reactive oxygen species. PloS one. 2013; 8(7):e69485. doi: 10.1371/journal.pone.0069485 PMID: 23922721
36. Czarnecka AM, Klemba A, Krawczyk T, Zdrozny M, Arnold RS, Bartnik E, et al. Mitochondrial NADHdehydrogenase polymorphisms as sporadic breast cancer risk factor. Oncology reports. 2010; 23 (2):531-5. PMID: 20043118
37. Jonsson PF, Bates PA. Global topological features of cancer proteins in the human interactome. Bioinformatics. 2006; 22(18):2291-7. doi: 10.1093/bioinformatics/btl390 PMID: 16844706
38. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proceedings of the National Academy of Sciences of the United States of America. 1998; 95(25):14863-8. PMID: 9843981
39. Swartz HM, Dunn JF. Measurements of oxygen in tissues: overview and perspectives on methods. Advances in experimental medicine and biology. 2003; 530:1-12. PMID: 14562699
40. Li LD, Sun HF, Liu XX, Gao SP, Jiang HL, Hu X, et al. Down-Regulation of NDUFB9 Promotes Breast Cancer Cell Proliferation, Metastasis by Mediating Mitochondrial Metabolism. PloS one. 2015; 10(12): e0144441. doi: 10.1371/journal.pone.0144441 PMID: 26641458
41. Dormeyer W, van Hoof D, Braam SR, Heck AJ, Mummery CL, Krijgsveld J. Plasma membrane proteomics of human embryonic stem cells and human embryonal carcinoma cells. Journal of proteome research. 2008; 7(7):2936-51. doi: 10.1021/pr800056j PMID: 18489135
42. Bai RK, Leal SM, Covarrubias D, Liu A, Wong LJ. Mitochondrial genetic background modifies breast cancer risk. Cancer research. 2007; 67(10):4687-94. doi: 10.1158/0008-5472.CAN-06-3554 PMID: 17510395
43. Putignani L, Raffa S, Pescosolido R, Aimati L, Signore F, Torrisi MR, et al. Alteration of expression levels of the oxidative phosphorylation system (OXPHOS) in breast cancer cell mitochondria. Breast cancer research and treatment. 2008; 110(3):439-52. doi: 10.1007/s10549-007-9738-x PMID: 17899367
44. Ivanov SV, Panaccione A, Nonaka D, Prasad ML, Boyd KL, Brown B, et al. Diagnostic SOX10 gene signatures in salivary adenoid cystic and breast basal-like carcinomas. British journal of cancer. 2013; 109(2):444-51. doi: 10.1038/bjc.2013.326 PMID: 23799842
45. Miyahara K, Kato Y, Koga H, Dizon R, Lane GJ, Suzuki R, et al. Visualization of enteric neural crest cell migration in SOX10 transgenic mouse gut using time-lapse fluorescence imaging. Journal of pediatric surgery. 2011; 46(12):2305-8. doi: 10.1016/j.jpedsurg.2011.09.020 PMID: 22152870
46. Mou Z, Tapper AR, Gardner PD. The armadillo repeat-containing protein, ARMCX3, physically and functionally interacts with the developmental regulatory factor Sox10. The Journal of biological chemistry. 2009; 284(20):13629-40. doi: 10.1074/jbc.M901177200 PMID: 19304657
47. Proia TA, Keller PJ, Gupta PB, Klebba I, Jones AD, Sedic M, et al. Genetic predisposition directs breast cancer phenotype by dictating progenitor cell fate. Cell stem cell. 2011; 8(2):149-63. doi: 10.1016/j.stem.2010.12.007 PMID: 21295272
48. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nature genetics. 2008; 40(5):499-507. doi: 10.1038/ng.127 PMID: 18443585
49. Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, Kumar RM, et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell. 2006; 125(2):301-13. doi: 10.1016/j.cell. 2006.02.043 PMID: 16630818
50. Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annual review of genetics. 2005; 39:359-407. doi: 10.1146/annurev. genet.39.110304.095751 PMID: 16285865
51. Kagawa Y, Cha SH, Hasegawa K, Hamamoto T, Endo H. Regulation of energy metabolism in human cells in aging and diabetes: FoF(1), mtDNA, UCP, and ROS. Biochemical and biophysical research communications. 1999; 266(3):662-76. doi: 10.1006/bbrc.1999.1884 PMID: 10603304
52. Turner-Ivey B, Guest ST, Irish JC, Kappler CS, Garrett-Mayer E, Wilson RC, et al. KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer. Neoplasia. 2014; 16(8):644-55. doi: 10.1016/j.neo.2014.07.007 PMID: 25220592
53. Amin R, Morita-Fujimura Y, Tawarayama H, Semba K, Chiba N, Fukumoto M, et al. DeltaNp63alpha induces quiescence and downregulates the BRCA1 pathway in estrogen receptor-positive luminal breast cancer cell line MCF7 but not in other breast cancer cell lines. Molecular oncology. 2016; 10 (4):575-93. doi: 10.1016/j.molonc.2015.11.009 PMID: 26704768